Everolimus-eluting stent shows equivalency to 1st and 2nd generation drug-eluting stents in terms of major cardiac adverse events at 1 year follow-up after Primary Percutaneous Coronary Intervention

EUROPEAN HEART JOURNAL(2010)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要